- Home
- IDR vs FENC Comparison
IDR vs FENC Comparison
Compare IDR & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDR
- FENC
- Stock Information
- Founded
- IDR 1996
- FENC 1996
- Country
- IDR United States
- FENC United States
- Employees
- IDR N/A
- FENC N/A
- Industry
- IDR Precious Metals
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IDR Basic Materials
- FENC Health Care
- Exchange
- IDR Nasdaq
- FENC Nasdaq
- Market Cap
- IDR 142.7M
- FENC 156.9M
- IPO Year
- IDR N/A
- FENC 2001
- Fundamental
- Price
- IDR $11.92
- FENC $5.74
- Analyst Decision
- IDR Strong Buy
- FENC Strong Buy
- Analyst Count
- IDR 1
- FENC 2
- Target Price
- IDR $14.00
- FENC $14.00
- AVG Volume (30 Days)
- IDR 128.7K
- FENC 68.3K
- Earning Date
- IDR 11-04-2024
- FENC 11-07-2024
- Dividend Yield
- IDR N/A
- FENC N/A
- EPS Growth
- IDR 344.27
- FENC N/A
- EPS
- IDR 0.52
- FENC N/A
- Revenue
- IDR $21,955,008.00
- FENC $49,348,000.00
- Revenue This Year
- IDR $86.37
- FENC $170.43
- Revenue Next Year
- IDR $11.11
- FENC $6.70
- P/E Ratio
- IDR $23.18
- FENC N/A
- Revenue Growth
- IDR 64.93
- FENC 278.09
- 52 Week Low
- IDR $5.75
- FENC $3.96
- 52 Week High
- IDR $18.35
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- IDR 60.99
- FENC 46.75
- Support Level
- IDR $10.55
- FENC $5.47
- Resistance Level
- IDR $10.81
- FENC $6.19
- Average True Range (ATR)
- IDR 0.51
- FENC 0.25
- MACD
- IDR 0.24
- FENC -0.09
- Stochastic Oscillator
- IDR 75.77
- FENC 24.77
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.